Reference
Institute for Clinical and Economic Review. ICER Releases Revised Draft Reports on Nucala (Mepolizumab) for Asthma and Tresiba (Insulin Degludec) for Diabetes. Internet Document : 27 Jan 2016. Available from: URL: http://www.icer-review.org/icer-releases-revised-draft-reports-on-nucala-mepolizumab-for-asthma-and-tresiba-insulin-degludec-for-diabetes/
Rights and permissions
About this article
Cite this article
ICER releases revised draft reports on Nucala, Tresiba. PharmacoEcon Outcomes News 746, 4 (2016). https://doi.org/10.1007/s40274-016-2782-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-2782-1